Government of Manitoba welcomes CDA draft to expand public coverage for Evrysdi and Spinraza
On 2026-10-28, Government of Manitoba said CDA draft backs wider SMA drug coverage; previously ineligible Manitobans with SMA are being reviewed.
Manitoba’s advocacy expands access to publicly funded SMA treatments; residents—including newcomers, students, workers, employers and families—can apply under CDA’s draft criteria, with specialist assessment and clinical requirements.
Health care workers are in demand across Canada. See if your occupation qualifies with the FREE evaluation: Occupation eligibility (NOC) (https://gloppap.com/evaluate/noc). Questions? Your Canadian AR, Joy Stephen (résumé: https://polinsys.co/joy), answers them at the FREE Q&A every Friday — join at https://myar.me/zoom.
Call Polinsys toll-free: 1-888-553-4833.